The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

  • Products Id :- GBI064CBR
  • |
  • Pages: 67
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets. Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval. Detailed case studies of recent Rx-to-OTC switches provide the rationale for these switches including description of their economic and financial impact.

The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. GBI Research expects M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios. A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets. The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years.

GBI Research conducted extensive primary and secondary research efforts in order to provide a comprehensive view of the regulatory, commercial and competitive landscape in the OTC drugs market. Our new report will let you assess the most promising commercial areas in the market and help you identify key opportunities and challenges.


How do consumers, payers and manufacturers benefit from Rx-to-OTC switches?

What are the key factors promoting the usage of OTC drugs?

Current trends in the OTC drugs market

What attitudes do consumers have towards OTC drugs?

How are new distribution channels, technologies and education reshaping the OTC drugs market?

What will be the impact of new regulatory initiatives and frameworks on future Rx-to-OTC switches in key markets?

What have been the preferred types of M&A deals in the OTC drugs market in recent years?

Which OTC drug manufacturers have been the most active in terms of mergers and acquisitions in recent years?

What are the current regulations and frameworks established in key developed and developing markets for OTC approval and Rx-to-OTC switches?

Which OTC drug product categories and drug classes have experienced the most switches in recent years?

Which new products categories are expected to enter the OTC drugs market in the coming years?

What has been the economic and financial impact of recent Rx-to-OTC switches?

Who are the leading OTC drug manufacturers and what are their OTC segments of interest?

Market analysis of the leading OTC product categories including cough, cold, and allergy, analgesics, gastrointestinal and dermatological drugs.

Reasons To Buy

This report will allow you to

Gain insights into the OTC drugs market and future prospects for Rx-to-OTC switches: This report comprehensively describes and assesses the commercial, regulatory and competitive landscape in this highly dynamic and lucrative industry.

Understand differing regulatory frameworks for OTC drugs and Rx-to-OTC switches in key markets: This report provides insights about established regulatory processes, approval frameworks and recent developments in the US, Europe, Japan, India and China for OTC drugs.

Assess M&A activity in the OTC drugs market: This report provides detailed analysis on M&A deals in recent years including trends on preferred types of deals, factors contributing to the surge in transactions and identifies the most active companies in the OTC drugs market.

Assess the market for the leading OTC product categories: Our new study provides market analyses of the key product categories including revenues in key national markets, key brands, key manufacturers, market drivers, restraints, recent switches and potential candidates for future Rx-to-OTC switch.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications



Key Global Trends in the OTC Drugs Market



APAC (India, China, Japan)

M&A Activity in the OTC Drugs Market: Leading Companies Consolidating their Market Position

Deal Analysis by Value, Type and Subtype

Drivers of the OTC Drugs Market

Barriers of the OTC Drugs Market

Current Regulations Surrounding OTC Drugs and Rx-to-OTC Switches




Recent Regulatory Trends and Developments in the OTC Drugs Market




Impact of Initiatives and Regulations (NSURE, Affordable Care Act) on Future Rx-to-OTC Switches

Rx-to-OTC Switch Case Studies: Key Benefits, Economic and Financial Impact

Nexium 24HR

Nasacort Allergy 24HR

Rhinocort Nasal Spray

Oxytrol For Women

Nicotine Replacement Therapies

Future Trends in the OTC Drugs Market and Rx-to-OTC Switches

Potential Drug Candidates for Future Rx-to-OTC Switch

Leading OTC Drug Manufacturers and Segments of Interest

Importance of Rx-to-OTC Strategies

Life Sciences Companies



Leading Product Categories in the OTC Drugs Market

Cough, Cold and Allergy OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Analgesic OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Dermatology OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis

Gastrointestinal OTC Drugs

Leading Brands and Key Manufacturers

Market Analysis



Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

OTC, over-the-counter pharmaceuticals market, Rx-to-OTC Switch, attitude towards self-medication

select a license

Single User License
USD 2995 INR 199437
Site License
USD 5990 INR 398874
Corporate User License
USD 8985 INR 598311



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]